Biomed Central Ltd

SHERPA: Unknown

People

Groups

  1. Department of Medicine (6)
  2. Melanoma and Immunotherapeutics Service (6)
  3. Solid Tumor Oncology Division (6)
  4. GSK Faculty (5)
  5. GDMT, Medicine (4)
  6. Gynecologic Medicine Service (4)
  7. Gynecology Disease Management Team (4)
  8. Sloan Kettering Institute Postdocs (1)
Search Within
  1. "Rikke Holmgaard"
Formats
  1. Meeting Abstract (6)
Groups
  1. Department of Medicine (6)
  2. Melanoma and Immunotherapeutics Service (6)
  3. Solid Tumor Oncology Division (6)
  4. GSK Faculty (5)
  5. GDMT, Medicine (4)
  6. Gynecologic Medicine Service (4)

More Groups

People
  1. Rikke Holmgaard (6)
  2. Jedd Wolchok (5)
  3. Dmitriy Zamarin (4)
  4. Taha Merghoub (4)
  5. David Schaer (1)
  6. James Allison (1)

More People

Years
  1. 2017 (1)
  2. 2015 (1)
  3. 2014 (2)
  4. 2013 (2)
Publications
  1. Journal for ImmunoTherapy of Cancer (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • AGEN2034, a novel anti-PD-1 antibody that combines effectively with CTLA-4 pathway blockade to enhance T cell activity
    Meeting Abstract

    Chand, D.; Savitsky, D.; Gonzalez, A.; Clarke, C.; Schuster, A.; Drouin, E. E.; Waight, J. D.; Mundt, C.; Ritter, G.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • The PTEN pathway in Tregs functions as a critical driver of the immunosuppressive tumor microenvironment and tolerance to apoptotic cells
    Meeting Abstract

    Sharma, M.; Shinde, R.; McGaha, T.; Huang, L.; Holmgaard, R.; Wolchok, J.; Mautino, M.; Celis, E.; Sharpe, A.; Francisco, L.; more...
    Journal for ImmunoTherapy of Cancer (2015)

    Fulltext@MSK | Save
  • Expression of indoleamine 2.3-dioxygenase by tumors induces local and systemic immunosuppressive effects in a murine melanoma model
    Meeting Abstract

    Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Merghoub, T.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Potentiation of immunomodulatory antibodies with oncolytic viruses for therapy of poorlyimmunogenic tumors
    Meeting Abstract

    Zamarin, D.; Holmgaard, R. B.; Plitt, T.; Allison, J.; Merghoub, T.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
    Meeting Abstract

    Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Wolchok, J. D.; Allison, J. P.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Localized oncolytic virotherapy inflames distant tumors and synergizes with immune checkpoint blockade leading to systemic tumor rejection
    Meeting Abstract

    Zamarin, D.; Holmgaard, R.; Subudhi, S.; Mansour, M.; Palese, P.; Merghoub, T.; Wolchok, J. D.; Allison, J. P.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save